Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Stratatech Corporation - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 23 | Code: MRS - 18618

Global Markets Directs, Stratatech Corporation Product Pipeline Review 2014, provides an overview of the Stratatech Corporations pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Stratatech Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.


The report provides brief overview of Stratatech Corporation including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Stratatech Corporations human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Stratatech Corporations pipeline products

Reasons to buy

Evaluate Stratatech Corporations strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Stratatech Corporation in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Stratatech Corporations R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Stratatech Corporation and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Stratatech Corporation
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Stratatech Corporation and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content 

Table of Contents 2
List of Tables 3
List of Figures 3
Stratatech Corporation Snapshot 4
Stratatech Corporation Overview 4
Key Information 4
Key Facts 4
Stratatech Corporation- Research and Development Overview 5
Key Therapeutic Areas 5
Stratatech Corporation- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Stratatech Corporation- Pipeline Products Glance 9
Stratatech Corporation- Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Stratatech Corporation- Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
Stratatech Corporation- Drug Profiles 12
StrataGraft Skin Tissue 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Cathelicidin 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Cell Therapy to Activate VEGF for Venous Leg Ulcers and Diabetic Foot Ulcers 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Interleukin-12 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Stratatech Corporation- Pipeline Analysis 18
Stratatech Corporation- Pipeline Products by Target 18
Stratatech Corporation- Pipeline Products by Molecule Type 19
Stratatech Corporation- Pipeline Products by Mechanism of Action 20
Stratatech Corporation- Locations And Subsidiaries 21
Head Office 21

Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23

List of Tables

Stratatech Corporation, Key Information 4
Stratatech Corporation, Key Facts 4
Stratatech Corporation- Pipeline by Indication, 2014 6
Stratatech Corporation- Pipeline by Stage of Development, 2014 7
Stratatech Corporation- Monotherapy Products in Pipeline, 2014 8
Stratatech Corporation- Phase II, 2014 9
Stratatech Corporation- Preclinical, 2014 10
Stratatech Corporation- Discovery, 2014 11
Stratatech Corporation- Pipeline by Target, 2014 18
Stratatech Corporation- Pipeline by Molecule Type, 2014 19
Stratatech Corporation- Pipeline Products by Mechanism of Action, 2014 20

List of Figures

Stratatech Corporation - Pipeline by Top 10 Indication, 2014 6
Stratatech Corporation - Pipeline by Stage of Development, 2014 7
Stratatech Corporation - Monotherapy Products in Pipeline, 2014 8
Stratatech Corporation - Pipeline by Top 10 Target, 2014 18
Stratatech Corporation - Pipeline by Top 10 Molecule Type, 2014 19
Stratatech Corporation - Pipeline Products by Top 10 Mechanism of Action, 2014 20

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing